Core Viewpoint - Limin Co., Ltd. achieved a net profit attributable to shareholders of 269 million yuan in the first half of the year, representing a year-on-year increase of 747.13% [1] Financial Performance - In Q2, the company realized a net profit attributable to shareholders of 161 million yuan, showing a year-on-year growth of 299.54% and a quarter-on-quarter increase of 48.66% [1] - The company's performance for the first half of 2025 is expected to continue growing at a rate of 747% year-on-year [1] Market Position and Strategy - The company has further solidified its position as a leading domestic pesticide manufacturer, focusing on technological innovation, global expansion, and green transformation [1] - There has been a continuous increase in market share, with major product prices and sales volumes rising year-on-year, alongside an improvement in gross profit margins [1] Research and Development - The company's technical research and development capabilities have been steadily enhanced, with progress in the chemical synthesis creation plan and successful collaboration with BASF on innovative drug development [1] - Product planning is being systematically developed, with improvements in formulation research and solid advancements in biological synthesis research [1] Market Outlook - The second half of the year marks the peak sales season in the South American market, with expected strong demand for fungicide products such as mancozeb and chlorothalonil, which will support continued market growth [1]
研报掘金丨国海证券:维持利民股份“买入”评级,核心产品量价齐升